Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objectives Performance of chest X-ray (CXR) features for PCP diagnosis has been evaluated in small studies. We conducted a systematic review and meta-analysis to describe CXR changes in adults with HIV-associated laboratory-confirmed PCP, comparing these to non-PCP respiratory disease. Methods We searched databases for studies reporting CXR changes in people > 15 years old with HIV and laboratory-confirmed PCP and those with non-PCP respiratory disease. CXR features were grouped using consensus terms. Proportions were pooled and odds ratios (OR) generated using random effects meta-analysis, with subgroup analyses by CD4 count, study period, radiology review method, and study region. Results 51 studies (with 1,821 PCP and 1,052 non-PCP cases) were included. Interstitial infiltrate (59%, 95% CI, 52-66%; 36 studies, n = 1,380, I2 85%) and ground-glass opacification (48%, 95% CI, 15-83%; 4 studies, n = 57, I2 86%) were common in PCP. Cystic lesions, central lymphadenopathy and pneumothorax were infrequent. Pleural effusion was rare in PCP (0% [95% CI, 0-2%]. Interstitial infiltrate (OR 2.3; 95% CI, 1.4-3.9; I2 = 60%); interstitial-alveolar infiltrate (OR 10.2 95% CI, 3.2-32.4; I2 = 0%); and diffuse CXR changes (OR 7.3; 95% CI, 2.7-20.2; I2 = 87%) were associated with PCP diagnosis. There was loss of association with alveolar infiltrate in African studies. Conclusions Diffuse CXR changes and interstitial-alveolar infiltrates indicate a higher likelihood of PCP. Pleural effusion, lymphadenopathy, or focal alveolar infiltrates suggest alternative causes. Findings could be incorporated into clinical algorithms to improve diagnosis of HIV-associated PCP.
Objectives Performance of chest X-ray (CXR) features for PCP diagnosis has been evaluated in small studies. We conducted a systematic review and meta-analysis to describe CXR changes in adults with HIV-associated laboratory-confirmed PCP, comparing these to non-PCP respiratory disease. Methods We searched databases for studies reporting CXR changes in people > 15 years old with HIV and laboratory-confirmed PCP and those with non-PCP respiratory disease. CXR features were grouped using consensus terms. Proportions were pooled and odds ratios (OR) generated using random effects meta-analysis, with subgroup analyses by CD4 count, study period, radiology review method, and study region. Results 51 studies (with 1,821 PCP and 1,052 non-PCP cases) were included. Interstitial infiltrate (59%, 95% CI, 52-66%; 36 studies, n = 1,380, I2 85%) and ground-glass opacification (48%, 95% CI, 15-83%; 4 studies, n = 57, I2 86%) were common in PCP. Cystic lesions, central lymphadenopathy and pneumothorax were infrequent. Pleural effusion was rare in PCP (0% [95% CI, 0-2%]. Interstitial infiltrate (OR 2.3; 95% CI, 1.4-3.9; I2 = 60%); interstitial-alveolar infiltrate (OR 10.2 95% CI, 3.2-32.4; I2 = 0%); and diffuse CXR changes (OR 7.3; 95% CI, 2.7-20.2; I2 = 87%) were associated with PCP diagnosis. There was loss of association with alveolar infiltrate in African studies. Conclusions Diffuse CXR changes and interstitial-alveolar infiltrates indicate a higher likelihood of PCP. Pleural effusion, lymphadenopathy, or focal alveolar infiltrates suggest alternative causes. Findings could be incorporated into clinical algorithms to improve diagnosis of HIV-associated PCP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.